Hubungan Indeks Massa Tubuh (IMT) dengan Kadar Serum Prostate Specific Antigen (PSA) pada Pasien Poliklinik Urologi RSUP H. Adam Malik
30
DAFTAR PUSTAKA
Arneth, Borros M., 2009. Clinical Significance of Measuring Prostate-specific
Antigen. Labmedicine; 40 (8): 487-491
AUA Commentary, 2000. Prostate-specific Antigen Best Practice Policy.
Oncology; 14(2): 267.
Brawer MK, Kirby R, 1999. Prostate Specific Antigen ed. 2nd. Singapore:
Health Press Limited
Chiang, Andrew S. et al, 2013. Utility of 5-Alpha-Reductase Inhibitors in
Active Surveillance for Favourable Risk Prostate Cancer. Can Urol
Assoc J; 7(11-12): 450-4533
Chiu, Peter Ka-Fung et al., 2011. Effect of Body Mass Index on Serum
Prostate-Specific Antigen Levels among Patients Presenting with
Lower Urinary Tract Symptoms. Asian Pacific Journal of Cancer
Prevention; 12:1937-1940
Durmaz, Tahir et al., 2014. Is There a Relationship Between Acute Coronary
Syndrome and Prostate Specific Antigen Level?. Urology Journal; 11
(1): 1278-1286
Eknoyan, Garabed, 2008. Adolphe Quetelet (1796-1874): The Average Man
and Indices of Obesity. Nephrol. Dial. Transplant; 23: 47–51
Erlangga N, Dimas, 2007. Ketepatan Diagnostik Prostat Spesifik Antigen pada
Keganasan Prostat di Rumah Sakit Dokter Kariadi Semarang.
Semarang: Fakultas Kedokteran Universitas Diponegoro
Garrow JS, Webster J., 1985. Quatelet’s Index (W/H)2 as A Measure of
Fatness. Int. J. Obes. Related Metabolic Disord.; 9: 147-153
Ganesh, B. et al., 2011. Risk Factors for Prostate Cancer: An Hospital-Based
Case-Control Study from Mumbai, India. Indian J Urol.; 27(3): 345–
350
Ikatan Ahli Urologi Indonesia, 2009. Pedoman Penatalaksanaan BPH di
Indonesia.
Universitas Sumatera Utara
31
Ikatan Ahli Urologi Indonesia, 2011. Pedoman Penatalaksanaan Kanker
Prostat.
Joseph E, Oesterling, 1991. Prostate Specific Antigen, a Crucial Assesment of
the Most Useful Tumor Markers for Adenocarcinoma of the Prostate.
The Journal Of Urology; 145: 907-923.
K. O. H, William et al., 2000. Neoplasm of the Prostate. Dalam: C. Bast,
Robert et al. Holland - Frei Cancer Medicine 5th ed.. USA : BC Decker
Inc
Lee, Sang Hun et al, 2013. Impact of Treatment with Statins on ProstateSpecific Antigen and Prostate Volume in Patients with Benign Prostatic
Hyperplasia. Korean Journal of Urology; 54: 750-755
Lilja H. et al, 1991. Prostate-specific Antigen in Serum occurs Predominately
in Complex with Α1-anticymptrypsin. Clin. Chem., 37: 1618-1625
Lionel L, Banez et al, 2007. Obesity-related Plasma Hemodilution and PSA
Concentration among Men with Prostate Cancer. The Journal of the
American Medical Association; 298: 2275–2280.
Montironi R, Mazzucchelli R, Algaba F., 2000. Prostate-specific Antigen as a
Marker of Prostate Disease. Virchows Arch.; 436: 297-304.
Muller, Heiko et al, 2009. Association of Diabetes and Body Mass Index with
Levels of Prostate-specific Antigen: Implications for Correction of
Prostate-specific Antigen Cutoff Values. Cancer Epidemiol Biomarkers
Prev; 18: 1350-1356
Partin, Alan W.. et al. 2012. Campbell-Walsh Urology, Tenth Edition:
Prostate. Amerika: Elsevier Saunders
Soegondo, Sidartawan & Purnamasari, Dyah, 2006. Sindrom Metabolik.
Dalam: Sudoyo, Aru W. dkk., 2009. Buku Ajar Ilmu Penyakit Dalam
jilid III ed. 5. Jakarta: Pusat Penerbitan Departemen Ilmu Penyakit
Dalam Fakultas Kedikteran Universitas Indonesia
Tanagho, Emil A., McAninch, Jack W., 2008. Smith’s General Urology edisi
17: Anatomy of the Genitourinary Tract. San Francisco: The McGrawHill Companies, Inc.
Universitas Sumatera Utara
32
WHO, 2000. Technical Report Series 894; Obesity; Preventing and Managing
the Global Epidemic. Swiss: WHO
WHO.
BMI Classification. Di akses pada: 26 Mei 2014.
http://apps.who.int/bmi/index.jsp?introPage=intro_3.html
Dari:
Universitas Sumatera Utara
DAFTAR PUSTAKA
Arneth, Borros M., 2009. Clinical Significance of Measuring Prostate-specific
Antigen. Labmedicine; 40 (8): 487-491
AUA Commentary, 2000. Prostate-specific Antigen Best Practice Policy.
Oncology; 14(2): 267.
Brawer MK, Kirby R, 1999. Prostate Specific Antigen ed. 2nd. Singapore:
Health Press Limited
Chiang, Andrew S. et al, 2013. Utility of 5-Alpha-Reductase Inhibitors in
Active Surveillance for Favourable Risk Prostate Cancer. Can Urol
Assoc J; 7(11-12): 450-4533
Chiu, Peter Ka-Fung et al., 2011. Effect of Body Mass Index on Serum
Prostate-Specific Antigen Levels among Patients Presenting with
Lower Urinary Tract Symptoms. Asian Pacific Journal of Cancer
Prevention; 12:1937-1940
Durmaz, Tahir et al., 2014. Is There a Relationship Between Acute Coronary
Syndrome and Prostate Specific Antigen Level?. Urology Journal; 11
(1): 1278-1286
Eknoyan, Garabed, 2008. Adolphe Quetelet (1796-1874): The Average Man
and Indices of Obesity. Nephrol. Dial. Transplant; 23: 47–51
Erlangga N, Dimas, 2007. Ketepatan Diagnostik Prostat Spesifik Antigen pada
Keganasan Prostat di Rumah Sakit Dokter Kariadi Semarang.
Semarang: Fakultas Kedokteran Universitas Diponegoro
Garrow JS, Webster J., 1985. Quatelet’s Index (W/H)2 as A Measure of
Fatness. Int. J. Obes. Related Metabolic Disord.; 9: 147-153
Ganesh, B. et al., 2011. Risk Factors for Prostate Cancer: An Hospital-Based
Case-Control Study from Mumbai, India. Indian J Urol.; 27(3): 345–
350
Ikatan Ahli Urologi Indonesia, 2009. Pedoman Penatalaksanaan BPH di
Indonesia.
Universitas Sumatera Utara
31
Ikatan Ahli Urologi Indonesia, 2011. Pedoman Penatalaksanaan Kanker
Prostat.
Joseph E, Oesterling, 1991. Prostate Specific Antigen, a Crucial Assesment of
the Most Useful Tumor Markers for Adenocarcinoma of the Prostate.
The Journal Of Urology; 145: 907-923.
K. O. H, William et al., 2000. Neoplasm of the Prostate. Dalam: C. Bast,
Robert et al. Holland - Frei Cancer Medicine 5th ed.. USA : BC Decker
Inc
Lee, Sang Hun et al, 2013. Impact of Treatment with Statins on ProstateSpecific Antigen and Prostate Volume in Patients with Benign Prostatic
Hyperplasia. Korean Journal of Urology; 54: 750-755
Lilja H. et al, 1991. Prostate-specific Antigen in Serum occurs Predominately
in Complex with Α1-anticymptrypsin. Clin. Chem., 37: 1618-1625
Lionel L, Banez et al, 2007. Obesity-related Plasma Hemodilution and PSA
Concentration among Men with Prostate Cancer. The Journal of the
American Medical Association; 298: 2275–2280.
Montironi R, Mazzucchelli R, Algaba F., 2000. Prostate-specific Antigen as a
Marker of Prostate Disease. Virchows Arch.; 436: 297-304.
Muller, Heiko et al, 2009. Association of Diabetes and Body Mass Index with
Levels of Prostate-specific Antigen: Implications for Correction of
Prostate-specific Antigen Cutoff Values. Cancer Epidemiol Biomarkers
Prev; 18: 1350-1356
Partin, Alan W.. et al. 2012. Campbell-Walsh Urology, Tenth Edition:
Prostate. Amerika: Elsevier Saunders
Soegondo, Sidartawan & Purnamasari, Dyah, 2006. Sindrom Metabolik.
Dalam: Sudoyo, Aru W. dkk., 2009. Buku Ajar Ilmu Penyakit Dalam
jilid III ed. 5. Jakarta: Pusat Penerbitan Departemen Ilmu Penyakit
Dalam Fakultas Kedikteran Universitas Indonesia
Tanagho, Emil A., McAninch, Jack W., 2008. Smith’s General Urology edisi
17: Anatomy of the Genitourinary Tract. San Francisco: The McGrawHill Companies, Inc.
Universitas Sumatera Utara
32
WHO, 2000. Technical Report Series 894; Obesity; Preventing and Managing
the Global Epidemic. Swiss: WHO
WHO.
BMI Classification. Di akses pada: 26 Mei 2014.
http://apps.who.int/bmi/index.jsp?introPage=intro_3.html
Dari:
Universitas Sumatera Utara